MARCHEX INC (MCHX) - Dilution Analysis

10-Q filing | 4.7M shares outstanding

10-K filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

8-K filing: Marchex has entered into an Agreement in Principle to acquire 100% of the stock of Archenia, Inc. for consideration including a convertible promissory note and potential future issuance of Class B common stock.

10-Q filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

10-K filing | 4.7M shares outstanding

8-K filing: On November 6, 2024, Marchex approved stock option grants of 50,000 options to each of its directors as compensation for their annual board service, with an exercise price equal to the closing price of Marchex's Class B common stock on the Grant Date and vesting over two years. Marchex also agreed to pay each independent director $7,500 in cash per quarter for their board service.

10-Q filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

10-K filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

8-K filing: Marchex granted directors restricted shares and options, and the Compensation Committee approved stock option grants to executive officers. ($0.0M proceeds)

10-Q filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

10-K filing | 4.7M shares outstanding

8-K filing: Marchex, Inc. approved stock option grants and grants of restricted stock to executive officers under the Corporation's 2021 Stock Incentive Plan effective on January 25, 2023.

8-K filing: On December 30, 2022, the Compensation Committee of Marchex, Inc. approved stock option grants and grants of restricted stock under the Corporation's 2021 Stock Incentive Plan to executive officers Russell C. Horowitz and Michael Arends.

10-Q filing | 4.7M shares outstanding

8-K filing: Marchex granted each director 15,000 restricted shares of Class B common stock at $0.01 per share and 20,000 options at an exercise price of $1.78 per share following the re-election of directors at the 2022 annual meeting of stockholders. ($0.0M proceeds)

10-Q filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

10-K filing | 4.7M shares outstanding

8-K filing: Marchex, Inc. granted stock options and restricted stock to executive officers under the 2021 Stock Incentive Plan on January 3, 2022.

8-K filing: Marchex, Inc. approved stock option grants and grants of restricted stock under the Corporation's 2012 Stock Incentive Plan effective on the Grant Date to executive officers.

10-Q filing | 4.7M shares outstanding

8-K filing: Marchex granted each of its directors 15,000 restricted shares of Class B common stock at a purchase price of $0.01 per share and 20,000 options at an exercise price of $3.02 per share as compensation for their annual board service. ($0.0M proceeds)

10-Q filing | 4.7M shares outstanding

10-Q filing | 4.7M shares outstanding

10-K filing | 4.8M shares outstanding

8-K filing: Marchex, Inc. granted stock options and restricted stock to executive officers on December 31, 2020, and January 4, 2021, under the Corporation's 2012 Stock Incentive Plan.

S-3/A filing: This S-3/A filing registers 3,582,960 shares of Class B common stock for resale by selling stockholders. Marchex will not receive any proceeds from the sale of these shares.

S-3 filing: This S-3 filing registers 3,582,960 shares of Class B common stock for resale by selling stockholders.

10-Q filing | 4.8M shares outstanding

8-K filing: Marchex granted each of its directors 15,000 restricted shares of Class B common stock at a purchase price of $.01 per share and 20,000 options at an exercise price of $1.90 per share. ($0.0M proceeds)

8-K filing: Marchex, Inc. announced the results of a joint and equal tender offer with Edenbrook Capital, LLC of up to 10 million shares of Marchex's Class B common stock at $2.15 per share, which expired on October 7, 2020. A total of 10,552,160 shares were properly tendered and not properly withdrawn at $2.15 per share. ($22.7M proceeds)

10-Q filing | 4.9M shares outstanding

8-K filing: Marchex, Inc. entered into an Asset Purchase Agreement with Archenia, Inc. for the sale of its mobile advertising network and related business operations for $2.25 million in cash, contingent consideration, shares of Class B common stock in the Purchaser equal to a 10% equity interest at closing, and the cancellation of Company stock options for 1.5 million shares held by Russell C. Horowitz and Michael Arends.

10-Q filing | 5.1M shares outstanding

10-K filing | 5.1M shares outstanding